🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Florida

Kliničke studije za Akutna mijeloidna leukemija u državi Florida

56 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u državi Florida.

Gradovi u državi Florida

Zvanični tekst studije (na engleskom)

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст 65 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06552416

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • UF Health Cancer Institute - Gainesville, Gainesville
  • Miami Cancer Institute, Miami
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • University of Miami, Miami
  • Moffitt Cancer Center & Research Institute, Tampa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Mayo Clinic in Florida, Jacksonville
  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Тражи се учесникФаза 2
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  • US-Orlando FL-ORLANDOHEALTH, Orlando
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07223814

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • и још 11
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  • Florida Cancer Specialists & Research Institute, Fort Myers
  • Jupiter Research, Jupiter
  • AdventHealth Medical Group Blood & Marrow Transplant at Orlando, Orlando
  • и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • UF Health Cancer Institute - Gainesville, Gainesville
  • Mayo Clinic in Florida, Jacksonville
  • Miami Cancer Institute, Miami
  • и још 6
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

  • University of Florida, Gainesville
Тражи се учесникФаза 1/2Здраве особе су добродошле
До 50 година · Оба пола · Ажурирано 30. 10. 2026. · NCT05322850

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT05429632

Study of REM-422 in Patients With AML or Higher Risk MDS

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06297941

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  • Mayo Clinic Hospital - Jacksonville, Jacksonville
  • University of Miami Health System, Miami
  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Тражи се учесникФаза 2
Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

  • Mayo Clinic in Florida, Jacksonville
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06279572

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

  • Moffitt Cancer Center and Research Institute Hospital, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06969430

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  • Moffitt Cancer Center /ID# 279192, Tampa
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07581002

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  • Clinical Trial Site, Tampa
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07211958

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06533761

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2
Узраст од 1 до 60 · Оба пола · Ажурирано 20. 10. 2026. · NCT03970096

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

  • H Lee Moffitt Cancer Center and Research Institute, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06846606

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616636

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1
Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • UF Health Cancer Institute - Gainesville, Gainesville
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
  • и још 10
Тражи се учесникФаза 3
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06504459

A Study of BGB-11417 in Participants With Myeloid Malignancies

  • Tampa General Hospital, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT04771130

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • Nemours Children's Clinic-Jacksonville, Jacksonville
  • Nemours Children's Hospital, Orlando
  • и још 1
Тражи се учесникФаза 3
Узраст од 1 до 25 · Оба пола · Ажурирано 4. 9. 2026. · NCT07022678

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT04588922

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  • US-Jacksonville FL-MAYOFL, Jacksonville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06652438

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Broward Health Medical Center, Fort Lauderdale
  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • UF Health Cancer Institute - Gainesville, Gainesville
  • и још 9
Тражи се учесникФаза 1/2
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • и још 2
Тражи се учесникФаза 1
Узраст од 18 до 75 · Оба пола · Ажурирано 25. 8. 2026. · NCT05886049

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

  • H Lee Moffitt Cancer Center & Research Institute, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT06656494

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

  • University of Miami, Miami
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 13. 8. 2026. · NCT07469592

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  • Bioresearch Partners, Miami
Тражи се учесникФаза 2/3
Узраст од 18 до 80 · Оба пола · Ажурирано 5. 8. 2026. · NCT06788756

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

  • University of Miami, Miami
  • AdventHealth Orlando, Orlando
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT05442216

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Florida Shands Medical Center, Gainesville
  • Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
  • University of Miami (peds), Miami
  • и још 6
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

  • University of Miami Health System, Coral Gables
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 6. 2026. · NCT05768932

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

  • University of Florida, Gainesville
Тражи се учесникФаза 2
6 Months – 39 Years · Оба пола · Ажурирано 4. 6. 2026. · NCT05800210

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.